20 October 2021 : Case report
A 46-Year-Old Woman with Primary Infertility and a Diagnosis of Microcystic Stromal Tumor of the Ovary Confirmed by Histology and Gene Sequencing: A Case Report and Review of the Literature
Challenging differential diagnosis, Rare disease, Educational Purpose (only if useful for a systematic review or synthesis)
Maria A. Arafah1ABCDEF*, Layla AlBreacan 2ABCDEF, Khalid Akkour3BCD, Suliman Alomar4BCDDOI: 10.12659/AJCR.933528
Am J Case Rep 2021; 22:e933528
Table 1. A summary of all previously published cases of an ovarian microcystic stromal tumor.
Case | Reference | Age | Molecular findings | Management | Follow-up (months) | |
---|---|---|---|---|---|---|
1 | Irving and Young, 2009 []1 | 62 | NA | TAH, BSO, LND, OM | NA | |
2 | 45 | TAH, BSO, peritoneal biopsies | ||||
3 | 51 | TAH, BSO, OM, appendectomy, pelvic washings | ||||
4 | 29 | LO | ||||
5 | 58 | TAH, BSO, LND, peritoneal biopsy, pelvic washings | ||||
6 | 26 | BSO | ||||
7 | 29 | RO | ||||
8 | 45 | LSO, endometrial curettage | ||||
9 | 63 | RO | ||||
10 | 56 | BSO | ||||
11 | 45 | TAH, BSO | ||||
12 | 55 | TAH, BSO | ||||
13 | 44 | TAH, BSO | ||||
14 | 36 | LSO | ||||
15 | 37 | TAH, BSO | ||||
16 | 39 | RSO, pelvic washings | ||||
17 | Maeda et al, 2011 []4 | 33 | CTNNB1 mutation | 1 GnRHa, RSO, enucleation of uterine masses, partial OM | NED (14) | |
18 | 41 | CTNNB1 mutation | RSO, enucleation of uterine leiomyoma | NED (4) | ||
19 | Yang and Bhattacharjee, 2014 []5 | 45 | NA | Open ovarian tumor resection | NA | |
20 | Niu and Peng, 2014 []6 | 42 | NA | NA | NA | |
21 | Irving et al, 2015 []7 | One of the cases was a 39-year-old patient with FAP | CTNNB1 mutation in 8/14 patients | NA | NA | |
22 | ||||||
23 | ||||||
24 | ||||||
25 | Kang et al, 2015 []8 | 41 | CTNNB1 mutation | Laparoscopic LSO | NA | |
26 | Lee et al, 2015 []9 | 40 | APC mutation | LSO, right ovarian wedge resection, total colectomy | NED (9) | |
27 | Bi et al, 2015 []10 | 69 | CTNNB1 mutation | LSO | NED (60) | |
28 | 29 | CTNNB1 wild-type | LO, right ovarian biopsy | NED (18) | ||
29 | 40 | CTNNB1 mutation | LO | NED (7) | ||
30 | 65 | CTNNB1 mutation | TAH, BSO | NA | ||
31 | 57 | CTNNB1 mutation | TAH, BSO | NED (59) | ||
32 | 41 | CTNNB1 wild-type | TAH, BSO, OM, appendectomy | NED (2) | ||
33 | Podduturi et al, 2015 []11 | 50 | CTNNB1 mutation | Hysterectomy, BSO, pelvic and para-aortic LND, OM, staging biopsies | NA | |
34 | Chen et al, 2015 []12 | 47 | NA | LSO | NED (18) | |
35 | Gunes et al, 2015 []13 | 52 | CTNNB1 mutation | TAH, BSO, OM | NED (3) | |
36 | Lee et al, 2016 []14 | 24 | CTNNB1 mutation | Laparoscopic LSO | NED (8) | |
37 | 31 | CTNNB1 mutation | Open LSO, para-aortic LND, peritonectomy | NED (3) | ||
38 | Liu, et al, 2016 []15 | 23 | APC mutation | Laparoscopic hysterectomy, RO, BS | NA | |
39 | Murakami et al, 2017 []16 | 26 | CTNNB1 wild-type | 4 GnRHa, LSO | NED (36) | |
40 | Na et al, 2017 []17 | 33 | CTNNB1 mutation | Laparoscopic RSO, partial OM | NED (57) | |
41 | 31 | CTNNB1 mutation | LSO, Para-aortic LND | NED (20) | ||
42 | Meurgey et al, 2017 []18 | 46 | FOXL2 and DICER1 wild-types | 2 LSO, 1 RSO | NA | |
43 | 37 | |||||
44 | 47 | |||||
45 | Qureshi et al, 2017 []19 | 50 | NA | LO | NA | |
46 | Jeong et al, 2018 []20 | 66 | NA | BSO, bilateral pelvic and para-aortic LND, infra-colic OM, peritoneal biopsies | NED (18) | |
47 | Zhang et al, 2018 []21 | 33 | APC mutation | Right laparoscopic cystectomy | Intraovarian and extraovarian recurrence (108) | |
48 | Hasanzadeh et al, 2019 []23 | 60 | NA | TAH, BSO | NED (15) | |
49 | McCluggage et al, 2019 []24 | 61 | CTNNB1 mutation | BSO | NA | |
50 | 56 | CTNNB1 mutation | Hysterectomy, BSO | |||
51 | 45 | NA | Hysterectomy, BSO | |||
52 | 71 | CTNNB1 mutation | BSO and endometrial curettage | |||
53 | Liu et al, 2019 []25 | 46 | NA | Laparoscopic RSO | NED (54) | |
54 | 56 | NA | Laparoscopic hysterectomy, BSO | NED (46) | ||
55 | Deng et al, 2020 []26 | 25 | NA | Laparoscopic resection of ovarian tumor | NED (4) | |
56 | He et al, 2020 []27 | 33 | NA | Laparoscopic resection of ovarian tumor | NED (19) | |
57 | Current case | 46 | CTNNB1 mutation | Open LSO, infra-colic OM, bilateral peritoneal biopsies, left pelvic LND, appendectomy | NED (24) | |
a Follow-up data were available for 7 patients with no evidence of disease after a mean period of 51 months. b The study evaluated 15 patients; 11 were included in Irving et al, 2009 and 4 were additional cases. c In 2017, the cases were re-examined by McCluggage et al for mutations. Two cases were initially reported to have wild-type showed mutations and 3 cases showed mutations including the patient with FAP. BEMP – benign endometrial polyp; BS – bilateral salpingectomy; BSO – bilateral salpingo-oophorectomy; EEA – endometrioid endometrial adenocarcinoma; FAP – familial adenomatous polyposis; GnRHa – gonadotropic releasing hormone analog; LND – lymph nodes dissection; LO – left oophorectomy; LSO – left salpingo-oophorectomy; NA – not available; NED – no evidence of disease; OM – omentectomy; RO – right oophorectomy; RSO – right salpingo-oophorectomy; TAH – total abdominal hysterectomy. |